{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:48:42Z","timestamp":1791676122223,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SNFMI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07038-5","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:55:33Z","timestamp":1782489333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France"],"prefix":"10.1007","volume":"105","author":[{"given":"Ondine","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cougoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kelly-Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Moulis.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"7038_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ncomms1104","volume":"1","author":"FB Piel","year":"2010","unstructured":"Piel FB, Patil AP, Howes RE et al (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1(1):104. https:\/\/doi.org\/10.1038\/ncomms1104","journal-title":"Nat Commun"},{"key":"7038_CR2","doi-asserted-by":"publisher","unstructured":"Piel FB, Steinberg MH, Rees DC. (2017) Sickle Cell Disease. Longo DL, ed. N Engl J Med. 376(16):1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","DOI":"10.1056\/NEJMra1510865"},{"key":"7038_CR3","unstructured":"Centre National de Coordination du D\u00e9pistage N\u00e9onatal. Rapport d\u2019activit\u00e9 2018 du Programme de d\u00e9pistage n\u00e9onatal. Published online August 2018. Accessed April 19, 2021. http:\/\/depistage-neonatal.org\/wp-content\/uploads\/2019\/12\/Rapport-Activite-2018.pdf"},{"issue":"11","key":"7038_CR4","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","volume":"103","author":"CT Quinn","year":"2004","unstructured":"Quinn CT, Rogers ZR, Buchanan GR (2004) Survival of children with sickle cell disease. Blood 103(11):4023\u20134027. https:\/\/doi.org\/10.1182\/blood-2003-11-3758","journal-title":"Blood"},{"issue":"17","key":"7038_CR5","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","volume":"115","author":"CT Quinn","year":"2010","unstructured":"Quinn CT, Rogers ZR, McCavit TL, Buchanan GR (2010) Improved survival of children and adolescents with sickle cell disease. Blood 115(17):3447\u20133452. https:\/\/doi.org\/10.1182\/blood-2009-07-233700","journal-title":"Blood"},{"issue":"10","key":"7038_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","volume":"128","author":"K Gardner","year":"2016","unstructured":"Gardner K, Douiri A, Drasar E et al (2016) Survival in adults with sickle cell disease in a high-income setting. Blood 128(10):1436\u20131438. https:\/\/doi.org\/10.1182\/blood-2016-05-716910","journal-title":"Blood"},{"issue":"3","key":"7038_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cger.2019.03.006","volume":"35","author":"AS Shet","year":"2019","unstructured":"Shet AS, Thein SL (2019) A Growing Population of Older Adults with Sickle Cell Disease. Clin Geriatr Med 35(3):349\u2013367. https:\/\/doi.org\/10.1016\/j.cger.2019.03.006","journal-title":"Clin Geriatr Med"},{"key":"7038_CR8","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole national de diagnostic et de soins, Syndrome dr\u00e9panocytaires majeurs de l\u2019adulte. Published online January 2010. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2010-04\/ald_10_guide_drepano_adulte_web.pdf"},{"key":"7038_CR9","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Protocole national de diagnostic et de soins, Syndromes dr\u00e9panocytaires majeurs de l\u2019enfant et de l\u2019adolescent. Published online January 2010. Accessed April 28, 2010. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2010-04\/ald_10_pnds_drepano_enfant_web.pdf"},{"issue":"6","key":"7038_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/bjh.14015","volume":"173","author":"N Couque","year":"2016","unstructured":"Couque N, Girard D, Ducrocq R et al (2016) Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines. Br J Haematol 173(6):927\u2013937. https:\/\/doi.org\/10.1111\/bjh.14015","journal-title":"Br J Haematol"},{"issue":"2","key":"7038_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.blre.2004.04.002","volume":"19","author":"DR Bonds","year":"2005","unstructured":"Bonds DR (2005) Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev 19(2):99\u2013110. https:\/\/doi.org\/10.1016\/j.blre.2004.04.002","journal-title":"Blood Rev"},{"issue":"1","key":"7038_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","volume":"2017","author":"E Vichinsky","year":"2017","unstructured":"Vichinsky E (2017) Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program 2017(1):435\u2013439","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"7038_CR13","doi-asserted-by":"publisher","unstructured":"Power\u2010Hays A, Patterson A, Sobota A (2020) Household material hardships impact emergency department reliance in pediatric patients with sickle cell disease. Pediatr Blood Cancer. 67(10). https:\/\/doi.org\/10.1002\/pbc.28587","DOI":"10.1002\/pbc.28587"},{"key":"7038_CR14","doi-asserted-by":"publisher","unstructured":"Glassberg JA, Wang J, Cohen R, Richardson LD, DeBaun MR. (2012) Risk Factors for Increased ED Utilization in a Multinational Cohort of Children With Sickle Cell Disease. Academic Emergency Med. 19(6):664\u2013672. https:\/\/doi.org\/10.1111\/j.1553-2712.2012.01364.x","DOI":"10.1111\/j.1553-2712.2012.01364.x"},{"key":"7038_CR15","doi-asserted-by":"publisher","unstructured":"Cronin RM, Hankins JS, Byrd J, et al. (2019) Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology. 24(1):189\u2013198. https:\/\/doi.org\/10.1080\/16078454.2018.1549801","DOI":"10.1080\/16078454.2018.1549801"},{"issue":"4","key":"7038_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/pubmed\/fdt100","volume":"35","author":"G AlJuburi","year":"2013","unstructured":"AlJuburi G, Laverty AA, Green SA, Phekoo KJ, Bell D, Majeed A (2013) Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study. J Public Health 35(4):510\u2013517. https:\/\/doi.org\/10.1093\/pubmed\/fdt100","journal-title":"J Public Health"},{"issue":"2","key":"7038_CR17","doi-asserted-by":"publisher","first-page":"e069075","DOI":"10.1136\/bmjopen-2022-069075","volume":"13","author":"J Gyamfi","year":"2023","unstructured":"Gyamfi J, Tampubolon S, Lee JT et al (2023) Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007\u20132018 National Health Interview Survey (NHIS). BMJ Open 13(2):e069075. https:\/\/doi.org\/10.1136\/bmjopen-2022-069075","journal-title":"BMJ Open"},{"key":"7038_CR18","doi-asserted-by":"publisher","unstructured":"Kayle M, Blewer AL, Pan W, et al. (2024) Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability \u2014 Sickle Cell Data Collection Program, 11 States, 2016\u20132020. MMWR Morb Mortal Wkly Rep. 73(12):248\u2013254. https:\/\/doi.org\/10.15585\/mmwr.mm7312a1","DOI":"10.15585\/mmwr.mm7312a1"},{"key":"7038_CR19","doi-asserted-by":"publisher","unstructured":"Ally SA, Han J, Sun R, et al. (2023) Community\u2010level socioeconomic distress is associated with nutritional status in adults with sickle cell anemia. eJHaem. 4(2):432\u2013436. https:\/\/doi.org\/10.1002\/jha2.661","DOI":"10.1002\/jha2.661"},{"key":"7038_CR20","doi-asserted-by":"publisher","unstructured":"Wahab S, Kelly K, Klingler M, et al. (2024) Impact of Race, Socioeconomic Status, and Geography on Healthcare Outcomes for Children With Sickle Cell Disease in the United States: A Scoping Review. Cureus. Published online 13 March 2024. https:\/\/doi.org\/10.7759\/cureus.56089","DOI":"10.7759\/cureus.56089"},{"issue":"1","key":"7038_CR21","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/MPH.0000000000001669","volume":"42","author":"L Cortright","year":"2020","unstructured":"Cortright L, Buckman C, Tumin D, Holder D, Leonard S (2020) Social Determinants of Health and Emergency Department Use Among Children With Sickle Cell Disease. J Pediatr Hematol Oncol 42(1):e42\u2013e45. https:\/\/doi.org\/10.1097\/MPH.0000000000001669","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"7038_CR22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1353\/hpu.2018.0060","volume":"29","author":"H Williams","year":"2018","unstructured":"Williams H, Silva S, Cline D, Freiermuth C, Tanabe P (2018) Social and Behavioral Factors in Sickle Cell Disease: Employment Predicts Decreased Health Care Utilization. J Health Care Poor Underserved 29(2):814\u2013829. https:\/\/doi.org\/10.1353\/hpu.2018.0060","journal-title":"J Health Care Poor Underserved"},{"key":"7038_CR23","doi-asserted-by":"publisher","unstructured":"Alishlash AS, Rutland SB, Friedman AJ, et al. (2021) Acute chest syndrome in pediatric sickle cell disease: Associations with racial composition and neighborhood deprivation. Pediatr Blood Cancer. 68(4). https:\/\/doi.org\/10.1002\/pbc.28877","DOI":"10.1002\/pbc.28877"},{"issue":"10","key":"7038_CR24","doi-asserted-by":"publisher","first-page":"e213467","DOI":"10.1001\/jamahealthforum.2021.3467","volume":"2","author":"J Kanter","year":"2021","unstructured":"Kanter J, Meier ER, Hankins JS, Paulukonis ST, Snyder AB (2021) Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data. JAMA Health Forum 2(10):e213467. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.3467","journal-title":"JAMA Health Forum"},{"issue":"4","key":"7038_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/1119-3077.91748","volume":"14","author":"B Animasahun","year":"2011","unstructured":"Animasahun B, Ogunkunle O, Njokanma O, Temiye E, Izuora A (2011) The influence of socioeconomic status on the hemoglobin level and anthropometry of sickle cell anemia patients in steady state at the Lagos University Teaching Hospital. Niger J Clin Pract 14(4):422. https:\/\/doi.org\/10.4103\/1119-3077.91748","journal-title":"Niger J Clin Pract"},{"issue":"9","key":"7038_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jpain.2008.04.002","volume":"9","author":"TM Palermo","year":"2008","unstructured":"Palermo TM, Riley CA, Mitchell BA (2008) Daily functioning and quality of life in children with sickle cell disease pain: Relationship with family and neighborhood socioeconomic distress. J Pain 9(9):833\u2013840. https:\/\/doi.org\/10.1016\/j.jpain.2008.04.002","journal-title":"J Pain"},{"key":"7038_CR27","doi-asserted-by":"publisher","unstructured":"Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States, p 5. https:\/\/doi.org\/10.1002\/pbc.22069","DOI":"10.1002\/pbc.22069"},{"issue":"6","key":"7038_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","volume":"36","author":"G Moulis","year":"2015","unstructured":"Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L (2015) French health insurance databases: What interest for medical research? Rev Med Interne 36(6):411\u2013417. https:\/\/doi.org\/10.1016\/j.revmed.2014.11.009","journal-title":"Rev Med Interne"},{"issue":"6","key":"7038_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/fcp.12214","volume":"30","author":"A Palmaro","year":"2016","unstructured":"Palmaro A, Moulis G, Despas F, Dupouy J, Lapeyre-Mestre M (2016) Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies. Fundam Clin Pharmacol 30(6):616\u2013624. https:\/\/doi.org\/10.1111\/fcp.12214","journal-title":"Fundam Clin Pharmacol"},{"issue":"8","key":"7038_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R et al (2017) The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 26(8):954\u2013962. https:\/\/doi.org\/10.1002\/pds.4233","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"7038_CR31","doi-asserted-by":"publisher","unstructured":"Walter O, Cougoul P, Zadro Y, Moulis G, Lafaurie M. Definition of an algorithm to identify patients with sickle-cell disease in the French National Health Database. European Journal of Internal Medicine. Published online June 2024:S0953620524002188. https:\/\/doi.org\/10.1016\/j.ejim.2024.05.012","DOI":"10.1016\/j.ejim.2024.05.012"},{"key":"7038_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejim.2020.04.030","volume":"79","author":"J Maquet","year":"2020","unstructured":"Maquet J, Derumeaux H, Lapeyre-Mestre M, Sailler L, Moulis G (2020) Validation of hemolytic anemia discharge diagnosis codes in the French hospital database. Eur J Intern Med 79:136\u2013138. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.030","journal-title":"Eur J Intern Med"},{"key":"7038_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/CLEP.S320666","volume":"13","author":"O Walter","year":"2021","unstructured":"Walter O, Maquet J, Derumeaux H, Moulis G, Lafaurie M (2021) Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database. Clin Epidemiol 13:717\u2013720. https:\/\/doi.org\/10.2147\/CLEP.S320666","journal-title":"Clin Epidemiol"},{"key":"7038_CR34","doi-asserted-by":"publisher","unstructured":"Rey G, Jougla E, Fouillet A, H\u00e9mon D (2009) Ecological association between a deprivation index and mortality in France over the period 1997 \u2013 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. Published online 2009:12. https:\/\/doi.org\/10.1186\/1471-2458-9-33","DOI":"10.1186\/1471-2458-9-33"},{"issue":"1\u20132","key":"7038_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000438859","volume":"74","author":"M Giroud","year":"2015","unstructured":"Giroud M, Hommel M, Benzenine E et al (2015) Positive Predictive Value of French Hospitalization Discharge Codes for Stroke and Transient Ischemic Attack. Eur Neurol 74(1\u20132):92\u201399. https:\/\/doi.org\/10.1159\/000438859","journal-title":"Eur Neurol"},{"issue":"2","key":"7038_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","volume":"54","author":"A Bannay","year":"2016","unstructured":"Bannay A, Chaignot C, Bloti\u00e8re PO et al (2016) The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Med Care 54(2):188\u2013194. https:\/\/doi.org\/10.1097\/MLR.0000000000000471","journal-title":"Med Care"},{"issue":"24","key":"7038_CR37","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2014-02-557439","volume":"123","author":"CC Sharpe","year":"2014","unstructured":"Sharpe CC, Thein SL (2014) How I treat renal complications in sickle cell disease. Blood 123(24):3720\u20133726. https:\/\/doi.org\/10.1182\/blood-2014-02-557439","journal-title":"Blood"},{"key":"7038_CR38","doi-asserted-by":"publisher","unstructured":"an behalf of French Study Group on Sickle Cell Disease, de Montalembert M, Beauvais P, Bachir D, Galacteros F, Girot R. (1993) Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. Eur J Pediatr. 152(3):201\u2013204. https:\/\/doi.org\/10.1007\/BF01956144","DOI":"10.1007\/BF01956144"},{"key":"7038_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajo.2018.09.025","volume":"197","author":"XJ Duan","year":"2019","unstructured":"Duan XJ, Lanzkron S, Linz MO, Ewing C, Wang J, Scott AW (2019) Clinical and Ophthalmic Factors Associated With the Severity of Sickle Cell Retinopathy. Am J Ophthalmol 197:105\u2013113. https:\/\/doi.org\/10.1016\/j.ajo.2018.09.025","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"7038_CR40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0929-693X(08)71894-3","volume":"15","author":"B-M Le","year":"2008","unstructured":"Le B-M (2008) d\u00e9pistage n\u00e9onatal de la dr\u00e9panocytose en France. Arch Pediatr 15(5):738\u2013740. https:\/\/doi.org\/10.1016\/S0929-693X(08)71894-3","journal-title":"Arch Pediatr"},{"key":"7038_CR41","doi-asserted-by":"publisher","unstructured":"Brousse V, Arnaud C, Lesprit E, et al. (2019) Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France. J Clin Med. 8(10). https:\/\/doi.org\/10.3390\/jcm8101594","DOI":"10.3390\/jcm8101594"},{"issue":"20","key":"7038_CR42","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1056\/NEJMp2022125","volume":"383","author":"A Power-Hays","year":"2020","unstructured":"Power-Hays A, McGann PT (2020) When Actions Speak Louder Than Words \u2014 Racism and Sickle Cell Disease. N Engl J Med 383(20):1902\u20131903. https:\/\/doi.org\/10.1056\/NEJMp2022125","journal-title":"N Engl J Med"},{"key":"7038_CR43","unstructured":"Robinson MR, Daniel LC, O\u2019Hara EA, Szabo MM, Barakat LP. Insurance Status as a Sociodemographic Risk Factor for Functional Outcomes and Health-related Quality of Life Among Youth With Sickle Cell Disease. Published online 2015:13."},{"issue":"5","key":"7038_CR44","doi-asserted-by":"publisher","first-page":"e28152","DOI":"10.1002\/pbc.28152","volume":"67","author":"M Kayle","year":"2020","unstructured":"Kayle M, Valle J, Paulukonis S et al (2020) Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease. Pediatr Blood Cancer 67(5):e28152. https:\/\/doi.org\/10.1002\/pbc.28152","journal-title":"Pediatr Blood Cancer"},{"issue":"26","key":"7038_CR45","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1182\/blood.2021014473","volume":"139","author":"O Walter","year":"2022","unstructured":"Walter O, Cougoul P, Maquet J et al (2022) Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood 139(26):3771\u20133777. https:\/\/doi.org\/10.1182\/blood.2021014473","journal-title":"Blood"},{"issue":"9757","key":"7038_CR46","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. The Lancet 376(9757):2018\u20132031. https:\/\/doi.org\/10.1016\/S0140-6736(10)61029-X","journal-title":"The Lancet"},{"issue":"1","key":"7038_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12889-016-4007-8","volume":"17","author":"J Bryere","year":"2017","unstructured":"Bryere J, Pornet C, Copin N et al (2017) Assessment of the ecological bias of seven aggregate social deprivation indices. BMC Public Health 17(1):86. https:\/\/doi.org\/10.1186\/s12889-016-4007-8","journal-title":"BMC Public Health"},{"issue":"1","key":"7038_CR48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12889-019-7220-4","volume":"19","author":"S Lamy","year":"2019","unstructured":"Lamy S, Molini\u00e9 F, Daubisse-Marliac L et al (2019) Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health 19(1):857. https:\/\/doi.org\/10.1186\/s12889-019-7220-4","journal-title":"BMC Public Health"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07038-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:59Z","timestamp":1791673559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7038"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07038-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7767414\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used anonymized national claims data, and no identifiable information was available. Therefore, individual consent to participate was not required.","order":1,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None related to this study. Outside of this study: GM: research funding from Amgen, Argenx, Grifols, Novartis, Sanofi; advisory boards for Alpine, Amgen, Argenx, Grifols, Novartis, Sanofi, Sobi.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"419"}}